+30.4%
GSK vs NBIX
+14.2%
+16.2%
-18.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | NBIX | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.9% | -1.7% | -0.2% | -1.7% |
| 7D | -1.8% | +1.0% | -2.9% | -1.9% |
| 30D | -2.2% | -3.6% | +1.5% | -1.7% |
| 3M | -1.8% | -7.0% | +5.2% | -1.1% |
| 6M | -10.6% | +16.6% | -27.2% | -11.9% |
| YTD | +4.4% | +9.7% | -5.3% | +2.8% |
| 1Y | +30.4% | +10.9% | +19.6% | +27.5% |
| All | +30.4% | +14.2% | +16.2% | +27.5% |
Cumulative growth
Daily Returns
Daily percentage return beside NBIX.
Daily Out/Under-Performance
Portfolio return minus NBIX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NBIX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded NBIX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling